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Development/Plasticity/Repair

Muscle Nicotinic Acetylcholine Receptors May Mediate
Trans-Synaptic Signaling at the Mouse Neuromuscular
Junction
X Xueyong Wang,1 J. Michael McIntosh,2,3 and X Mark M. Rich1
1Department of Neuroscience, Cell Biology, and Physiology, Wright State University, Dayton, Ohio 45435, 2George E. Wahlen Veterans Affairs Medical
Center, Salt Lake City, UT 84108, and 3Department of Psychiatry, University of Utah, Salt Lake City, UT 84112

Block of neurotransmitter receptors at the neuromuscular junction (NMJ) has been shown to trigger upregulation of the number of
synaptic vesicles released (quantal content, QC), a response termed homeostatic synaptic plasticity. The mechanism underlying this
plasticity is not known. Here, we used selective toxins to demonstrate that block of ␣1-containing nicotinic acetylcholine receptors
(nAChRs) at the NMJ of male and female mice triggers the upregulation of QC. Reduction of current flow through nAChRs, induced by
drugs with antagonist activity, demonstrated that reduction in synaptic current per se does not trigger upregulation of QC. These data led
to the remarkable conclusion that disruption of synaptic transmission is not sensed to trigger upregulation of QC. During studies of the
effect of partial block of nAChRs on QC, we observed a small but reproducible increase in the decay kinetics of miniature synaptic
currents. The change in kinetics was correlated with the increase in QC and raises the possibility that a change in postsynaptic nAChR
conformation may be associated with the presynaptic increase in QC. We propose that, in addition to functioning in synaptic transmission, ionotropic muscle nicotonic nAChRs may serve as signaling molecules that participate in synaptic plasticity. Because nAChRs have
been implicated in a number of disease states, the finding that nAChRs may be involved in triggering synaptic plasticity could have
wide-reaching implications.
Key words: endplate; homeostatic; neurotransmitter; plasticity; synaptic; transmission

Significance Statement
The signals that initiate synaptic plasticity of the nervous system are still incompletely understood. Using the mouse neuromuscular junction as a model synapse, we studied how block of neurotransmitter receptors is sensed to trigger synaptic plasticity. Our
studies led to the surprising conclusion that neither changes in synaptic current nor spiking of the presynaptic or postsynaptic cell
are sensed to initiate synaptic plasticity. Instead, postsynaptic nicotinic acetylcholine receptors (nAChRs), in addition to functioning in synaptic transmission, may serve as signaling molecules that trigger synaptic plasticity. Because nAChRs have been
implicated in a number of disease states, the finding that they may mediate synaptic plasticity has broad implications.

Introduction
The signals that initiate synaptic plasticity of the nervous system
are still incompletely understood. The neuromuscular junction
(NMJ) is a synaptic preparation ideally suited to studies of synaptic plasticity because there is only one neurotransmitter and
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neurotransmitter receptor type present. At the adult mouse NMJ,
release of acetylcholine (ACh) from the presynaptic terminal
binds and opens a single type of nicotinic acetylcholine receptor
(nAChR) containing two identical ␣ subunits and a ␤, a ␦, and an
 subunit (Auerbach, 2015). The presence of a uniform population of nAChRs simplifies interpretation of experiments in which
plasticity of the synapse is studied in response to partial block of
receptors.
Block of synaptic transmission at the NMJ triggers rapid upregulation of presynaptic transmitter release that serves to counteract the block of transmission and is thus termed homeostatic
synaptic plasticity (Rich and Wenner, 2007; Turrigiano, 2012;
Davis and Müller, 2015). A number of different blockers of
nAChRs have been found to trigger increases of the number of

Wang et al. • Acetylcholine Receptors Mediate Synaptic Plasticity

1726 • J. Neurosci., February 14, 2018 • 38(7):1725–1736

synaptic vesicles released (quantal content, QC) to homeostatically regulate synaptic current at the NMJ of multiple species
including mouse and human (Katz and Miledi, 1978; Miledi et
al., 1978; Molenaar et al., 1979, 1991; Cull-Candy et al., 1980;
Wilson, 1982; Harborne et al., 1988; Plomp et al., 1992, 1994;
Tian et al., 1994; Plomp et al., 1995; Wang et al., 2010, 2016).
Homeostatic regulation of synaptic current also occurs at the
glutamatergic Drosophila NMJ after block of glutamate receptors
(Frank et al., 2006). These studies suggest homeostatic regulation
of QC at the NMJ is an evolutionarily conserved phenomenon.
There are at least two distinct forms of homeostatic upregulation of QC at the mouse NMJ. The first is triggered by block of
neurotransmitter receptors and the mechanism is an increase in
the number of releasable vesicles (the binomial parameter n); the
second is triggered by block of evoked release and the mechanism
is an increase in the probability of release (the binomial parameter p) (Wang et al., 2010). These pathways can be triggered independently and are additive (Wang et al., 2010).
It is not clear how disruption of synaptic activity is sensed to
trigger homeostatic plasticity. Possibilities include spiking of the
postsynaptic cell and block of synaptic transmission. At the Drosophila
NMJ, the increase in QC occurs in the absence of evoked activity
(Frank et al., 2006), suggesting that neither loss of spiking of muscle
fibers nor block of evoked release of neurotransmitter is the signal
that triggers upregulation of QC. Similarly, it has been found that
homeostatic regulation of quantal amplitude in neurons occurs independently of spiking activity (Garcia-Bereguiain et al., 2016). It is
assumed that current flow or depolarization occurring during spontaneous release of neurotransmitter is what is sensed to trigger the
homeostatic response.
We probed how partial block of nAChRs is sensed to trigger
homeostatic synaptic plasticity at the mouse NMJ. Our data suggest that block of postsynaptic ␣1-containing nAChRs triggers
presynaptic plasticity and led to the surprising conclusion that
neither evoked nor spontaneous synaptic transmission is sensed.
Our data raise the possibility that binding of toxin to nAChRs
triggers trans-synaptic signaling and the presynaptic increase
in QC.

Materials and Methods
Ethical approval. All procedures involving animals were approved by the
Wright State institutional animal care and use committee.
Mice. To easily visualize NMJs, mice expressing the YFP transgene
driven by the Thy-1 promoter were used [B6.Cg-Tg(Thy1-YFP)16Jrs/J;
The Jackson Laboratory). Mice with ␣7 subunit of nicotinic nAChRs
knock-out were also obtained from The Jackson Laboratory (Chrna7).
Both male and female mice were used for all experiments. No differences
were noted between male and female mice.
Electrophysiological recording. The experimental procedures used to
measure QC in the mouse tibialis anterior muscle have been described
previously (Wang et al., 2004, 2016). Briefly, 2- to 3-month-old mice
were killed using CO2 inhalation and the tibialis anterior muscle was
removed, pinned in a Sylgard plated dish and stained with 10 M 4-(4diethylaminostyryl)-N-methylpyridinium iodide (4-Di-2ASP; Invitrogen) to visualize NMJs using an upright epifluorescence microscope.
Muscle strips were perfused at a speed of 3– 6 ml per minute with external
solution containing the following (in mM): 118 NaCl, 0.7 MgCl2, 2
CaSO4, 3.5 KCl, 26.2 NaHCO3, 1.7 NaH2PO4, and 5.5 glucose, equilibrated with 95% O2 and 5% CO2, pH 7.3–7.4, 20 –22°C. For experiments
in which temperature was increased to 32°C, an automatic temperature
controller (Warner Instruments) was used.
Endplates were imaged and muscle fibers were impaled within 100 m
of the NMJ to ensure good space clamp of the NMJ region. Endplate
currents (EPCs) were recorded using two-electrode voltage clamp while

the nerve branch to the tibialis anterior muscle was stimulated via a
tungsten bipolar electrode (FHC).
Unless otherwise indicated, muscle fibers were crushed on both ends
away from the NMJ band to eliminate contractions upon nerve stimulation and the holding potential was set at ⫺45 mV. In some experiments,
a more negative potential was required to detect miniature EPCs
(mEPCs) due to block of postsynaptic nAChRs. In these experiments,
muscle fibers were not crushed and contraction was prevented by addition of -conotoxin GIIIB (-Ctx; Alomone Labs) to the external solution (final toxin concentration was 1–3 M) to inhibit muscle Na ⫹
channels. We have shown that QC obtained from both preparations is
identical (Wang et al., 2004, 2005).
The QC corresponding to a given EPC was calculated from the ratio of
the amplitude the EPC to the average of amplitude of at least 20 mEPCs
obtained during the 20 s before and the 20 s after the EPC. For bars graphs
of QC before and after block of nAChRs, EPC amplitude was determined
from an average of 10 EPCs evoked at 0.5 Hz, whereas mEPC amplitude
was determined from an average obtained from at least 30 mEPCs recorded over a 1 min period.
Drugs. Drugs were applied either by adding into the bathing solution
or by pressure puff delivery with a picospritzer II (20 psi) as described
previously (Wang et al., 2016). ␣-bungarotoxin (BTX), D-tubocurarine
(D-TC), carbachol (CCh), vecuronium bromide, succinylcholine chloride, gallamine, mecamylamine hydrochloride, atropine, and acetylcholine chloride were all from Sigma-Aldrich. ␣-conotoxin MI (␣-CtxMI)
and ␣-conotoxin ArIB[V11L;V16D] (␣-CtxArIB) were provided by Dr.
McIntosh.
Experimental design and statistical analysis. Data were recorded from
the same muscle (often the same NMJ) before and after drug treatment.
Nested ANOVA (SYSTAT; Systat Software) was used for comparing the
effect of drugs and other experimental manipulations. Details of the
statistical tests used and the values obtained are listed in Table 1. Plots
and curve fittings were made using Sigmaplot software (Systat Software).
Averaged results are expressed as mean ⫾ SE. p ⬍ 0.05 and p ⬍ 0.01 are
denoted by one and two asterisks, respectively.

Results
Block of nAChRs triggers upregulation of QC independently
of evoked release, membrane potential, and synaptic current
We and others found previously that block of nAChRs at the
mammalian NMJ at room temperature triggers an increase in QC
(Katz and Miledi, 1978; Miledi et al., 1978; Molenaar et al., 1979,
1991; Cull-Candy et al., 1980; Wilson, 1982; Harborne et al.,
1988; Plomp et al., 1992, 1994; Tian et al., 1994; Plomp et al.,
1995; Wang et al., 2010, 2016). To confirm that the finding is
physiologically relevant, we examined whether it occurred at the
more physiologic temperature of 32°C. Increasing temperature
to 32°C increased mean mEPC amplitude from 1.44 ⫾ 0.14 to
1.90 ⫾ 0.08 nA (n ⫽ 8 NMJs) and accelerated the rate of decay
from 1.04 ⫾ 0.07 to 0.59 ⫾ 0.04 ms. There was no effect on QC
(56.6 ⫾ 2.6 to 55.8 ⫾ 2.5, t(7) ⫽ 1.6, p ⫽ 0.15). These results are
similar to temperature-dependent changes reported previously at
a central synapse (Kushmerick et al., 2006). The finding that QC
does not change with increased temperature suggests that neither
the number of releasable vesicles nor the probability of release has
significant temperature dependence. When the temperature was
32°C, the addition of 0.1 M D-TC triggered an increase in QC
(45.1%, n ⫽ 9 NMJs, t(8) ⫽ ⫺4.765, p ⫽ 0.001) that was similar to
the increase occurring at room temperature. These data suggest
that, at both room temperature and at physiologic temperature,
partial block of nAChRs triggers an increase in QC.
There are several ways that the postsynaptic cell might sense
reduction in synaptic activity. One is through reduction in postsynaptic spiking activity. This has been the mechanism proposed
for detection of reduced network activity in neuronal systems
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Table 1. Data statistics
Reference
Temperature
Fig. 1D
Fig. 2A
Fig. 2A

Fig. 2B
Fig. 3C
Fig. 3G

Fig. 3H

Fig. 3H

Fig. 3H

Fig. 4A

Fig. 4A

Fig. 4B

Fig. 4B

Fig. 4D

Fig. 4D

Fig. 5B

Test
o

Raise to 32 C on QC
D-TC on QC at 32 oC
Holding at ⫺40 mV and ⫺90 mV on QC
Baseline QC (QC)
D-TC on QC
Control
␣CtxArIB
Atropine
␣7KO
␣-Ctx MI on QC
D-TC on QC with CCh puff
Effect of ACh
EPC
mEPC
QC
Ctrl vs ⫹ACh ⫹ atropine
EPC
mEPC
QC
Ctrl vs ACh ⫹ atropine ⫹ D-TC
EPC
mEPC
QC
ACh ⫹ atropine vs ACh ⫹ atropine ⫹ D-TC
EPC
mEPC
QC
Before vs vecuronium
EPC
mEPC
QC
Vecuronium vs washout
EPC
mEPC
QC
Before vs mecamylamine
EPC
mEPC
QC
Mecamylamine vs washout
EPC
mEPC
QC
Before vs succinylcholine
EPC
mEPC
QC
Succinylcholine vs washout
EPC
mEPC
QC
mEPC decay tau change by
BTX
D-TC
Gallamine (GT)
Mecamylamine
Vecuronium
Succinylcholine
ACh/CCh
BTX vs ACh/CCh on decay tau

(Turrigiano, 2012). In our system, this was not a possibility because postsynaptic spiking was prevented by crushing muscle
fibers to depolarize the membrane potential and inactivate sodium channels. Despite the loss of postsynaptic spiking, partial

Result

Method

t(7) ⫽ 1.626, p ⫽ 0.148
t(8) ⫽ ⫺4.765, p ⫽ 0.00142
t(9) ⫽ ⫺0.635, p ⫽ 0.541
F(3,15) ⫽ 0.805, p ⫽ 0.499

Paired t test
Paired t test
Paired t test
ANOVA
Paired t test

t(21) ⫽ ⫺11.467, p ⫽ 1.67E-10
t(8) ⫽ ⫺10.814, p ⫽ 4.72E-6
t(4) ⫽ ⫺8.102, p ⫽ 0.00126
t(19) ⫽ ⫺7.316, p ⫽ 6.15E-7
F(2,6) ⫽ 9.787, p ⬍ 0.0001
t(9) ⫽ ⫺15.213, p ⫽ 9.98E-8

ANOVA
ANOVA
ANOVA

F(1,8) ⫽ 72.463, p ⬍ 0.0001
F(1,8) ⫽ 184.117, p ⬍ 0.0001
F(1,8) ⫽ 0.267, p ⫽ 0.667
ANOVA
F(1,6) ⫽ 25.143 p ⬍ 0.0001
F(1,6) ⫽ 31.179, p ⱕ 0.0001
F(1,6) ⫽ 0.026, p ⫽ 0.873
ANOVA
F(1,6) ⫽ 70.508, p ⱕ 0.0001
F(1,6) ⫽ 269.432, p ⱕ 0.0001
F(1,6) ⫽ 25.644, p ⱕ 0.0001
ANOVA
F(1,6) ⫽ 10.924, p ⫽ 0.001
F(1,6) ⫽ 250.029, p ⱕ 0.0001
F(1,6) ⫽ 25.644, p ⱕ 0.0001
ANOVA
F(1,10) ⫽ 126.367, p ⬍ 0.0001
F(1,10) ⫽ 805.135, p ⬍ 0.0001
F(1,10) ⫽ 42.313, p ⬍ 0.0001
ANOVA
F(1,10) ⫽ 54.36, p ⬍ 0.0001
F(1,10) ⫽ 596.527, p ⬍ 0.0001
F(1,10) ⫽ 27.124, p ⬍ 0.0001
ANOVA
F(1,4) ⫽ 7.92, p ⫽ 0.006
F(1,4) ⫽ 338.71, p ⬍ 0.0001
F(1,4) ⫽ 54.659, p ⬍ 0.0001
ANOVA
F(1,4) ⫽ 10.835, p ⫽ 0.002
F(1,4) ⫽ 602.623, p ⬍ 0.0001
F(1,4) ⫽ 39.211, p ⬍ 0.0001
ANOVA
F(1,8) ⫽ 273.314, p ⬍ 0.0001
F(1,8) ⫽ 493.958, p ⬍ 0.0001
F(1,8) ⫽ 0.528, p ⫽ 0.498
ANOVA
F(1,8) ⫽ 110.816, p ⬍ 0.0001
F(1,8) ⫽ 172.376, p ⬍ 0.0001
F(1,8) ⫽ 0.486, p ⬍ 0.487
Paired t test
t(18) ⫽ 6.458, p ⫽ 4.48E-6
t(17) ⫽ 12.355, p ⫽ 1.35E-9
t(9) ⫽ 5.825, p ⫽ 2.52E-4
t(4) ⫽ 7.263, p ⫽ 0.00191
t(12) ⫽ 5.048, p ⫽ 2.85E-4
t(11) ⫽ ⫺1.956, p ⫽ 0.0790
t(21) ⫽ 3.705, p ⫽ 0.0014
t(38) ⫽ 4.197, p ⫽ 1.57E-4

t test

block of nAChRs by D-TC triggered rapid upregulation of QC
(Fig. 1 A, B).
A second possibility is that depolarization of the postsynaptic
muscle fiber during evoked release is sensed to trigger the homeo-
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Figure 2. Increase in QC is triggered by block of nAChRs containing ␣1 subunits. A, QC was
measured before and in the presence of D-TC (0.1 M) in control muscle (n ⫽ 8 mice, 22 NMJs),
in muscle pretreated with atropine (10 M) to block muscarinic AChRs (2 mice, 5 NMJs), in
muscle pretreated with ␣-CtxArIB (17 nM) to block ␣7 containing nAChRs (3 mice, 9 NMJs), and
in muscle from mice lacking nAChRs composed of ␣7 subunits (6 mice, 20 NMJs). There was no
significant difference in baseline QC among the 4 groups (F(3,15) ⫽ 0.805, p ⫽ 0.499, ANOVA)
and D-TC triggered a significant increase in QC in all 4 groups (Table 1). B, QC is significantly
increased by ␣-Ctx MI (40 nM), which blocks nAChRs containing the ␣1 subunit. Control, n ⫽ 3
mice, 30 NMJs; in the presence of ␣-Ctx MI, n ⫽ 3 mice, 50 NMJs. ANOVA, F(2,6) ⫽ 9.787, p ⫽
0.0001.

Figure 1. Rapidly reversible increase in QC is triggered independent of synaptic current and
evoked release. A, Increase in QC triggered by blocking nAChRs is not dependent on evoked ACh
release. EPC (top) and mEPC (middle) were recorded alternately by repeating the protocol
shown in the bottom row of B. The corresponding QC was calculated from the ratio of the EPC
amplitude/average mEPC (see Materials and Methods) and plotted in the bottom trace. The
bathing solution contained 0.1 ⌴ D-TC as indicated by striped bar. Nerve stimulation/EPC
collection was paused during D-TC infusion. Ba, Representative traces of EPC and mEPC, from
the experiment shown in A before (gray) and during (red) infusion of D-TC at the times indicated
by the correspondingly colored arrows in A. Bb, Recording protocol used for experiments in
which QC was followed in individual fibers during infusion of nAChR blockers. Two EPCs at 0.5 Hz
and 20 s of mEPCs were alternately recorded and the averaged values were used to calculate
corresponding QC and construct the plot (e.g., A and C). EPC and mEPC amplitudes are scaled
differently so that both fit on the same plot. C, QC is not affected by varying EPC and mEPC
amplitude by changing the muscle fiber holding potential. Using 2-electrode voltage clamp, the
muscle voltage in the region of the endplate was varied by 5 mV every minute (top, green circle).
Muscle action potentials were prevented by the presence of 2 ⌴ -conotoxin in the bathing
solution. The holding current (top, purple circle) is also plotted. EPCs and mEPCs (middle) were
acquired alternately by repeating the protocol shown in Bb. The calculated QC is shown at the
bottom and was unvarying despite a ⬎2-fold change in EPC and mEPC amplitude. D, EPC and
mEPC were collected at holding potentials of both ⫺40 mV and ⫺90 mV on 10 NMJs and QC was
compared. Holding potential exerted no significant effect on QC (t(9) ⫽ ⫺0.635, p ⫽ 0.541).

static upregulation of QC. We tested this possibility in two ways.
First, we voltage clamped individual muscle fibers such that the
membrane potential in the region of the NMJ was constant before, during, and after the infusion of D-TC. Despite a constant
membrane potential, QC was still upregulated by infusion of
D-TC (Fig. 1A). Second, we measured QC in individual NMJs

and then infused D-TC in the absence of presynaptic spikes triggered by nerve stimulation. The increase in QC was evident in the
EPC evoked by the very first nerve stimulation after infusion of
D-TC (Fig. 1A. n ⫽ 6 NMJs), but not when D-TC was omitted
(n ⫽ 4 NMJs). These data indicate that the increase in QC can
occur in the absence of changes in muscle membrane potential
and in the absence of prior evoked release.
The upregulation of QC could be triggered by interruption of
nAChRs activation during spontaneous release of ACh. Spontaneous release of vesicles containing ACh occurs at the NMJ at a
rate of ⬃1 Hz and triggers mEPCs. One way that mEPCs might
signal is through depolarization of the membrane potential; however, this was ruled out by the voltage-clamp experiments described above. The next possibility that we considered is that
reduction in mEPC current (rather than depolarization) is sensed
to trigger the upregulation of QC. We altered the holding potential of the postsynaptic muscle fiber to alter driving force for
current flow through nAChRs (Fig. 1C,D). Increasing and decreasing mEPC amplitude by twofold by altering holding potential had no effect on QC (Fig. 1C,D). These data suggest that
reduction in postsynaptic current is not the trigger of increases
in QC.
Block of nicotinic ␣1 containing nAChRs triggers the increase
in QC
The finding that reduction in postsynaptic current does not trigger upregulation of presynaptic QC caused us to consider that the
nAChRs triggering the upregulation of QC might be on either the
presynaptic terminal or the Schwann cell. Evidence for the presence of AChRs on terminal Schwann cells at the mouse NMJ
comes from a study showing that Schwann cell Ca 2⫹ transients
are triggered by nerve stimulation or application of ACh (Rochon
et al., 2001). Muscarinic AChRs appear to be involved as the
Schwann cell Ca 2⫹ transients were blocked by atropine and were
unaffected by application of BTX (Rochon et al., 2001). We applied atropine to muscles and found this triggered no change in
QC (Fig. 2A). Application of D-TC after application of atropine
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Figure 3. Upregulation of QC is independent of synaptic function. A, Pulsatile application of the agonist CCh that produces large CCh-gated currents does not prevent the D-TC-induced increase
in QC. EPC, puffed CCh-evoked current, and mEPC were acquired alternately by the protocol shown in Cb. Average EPC (up triangle, open, average mEPC (down triangle), and QC (square, open) were
plotted against time. For comparison, the value of CCh-evoked current (up triangle, filled) was normalized to that of EPC recorded before D-TC infusion, and the ratio of CCh-evoked current/mEPC
were also plotted (square, filled) along-side QC. The bathing solution was switched to a solution containing 0.1 M D-TC as indicated by horizontal bars. B, Representative traces of EPC, CCh-evoked
current, and mEPC were taken at times denoted by the numbers in A. Ca, Comparison of QC increases (percentage of control) by D-TC infusion with (n ⫽ 22, same data as in Fig. 2A control) /without
(n ⫽ 11) puffing of CCh (t(9)⫽⫺15.213, p ⫽ 9.98E-8, paired t). Cb, Protocol used in A. It is a variation of protocol shown in Figure 1Bb. with addition of pressure puffing of agonist onto the NMJ
being recorded after acquisition of EPC and recording of 25 s mEPC in each cycle. D, Total postsynaptic current for a given time period of the recording shown in A was measured by taking the integral
of the various currents over each 25 s epoch. The top panel is a plot of the summed integrals of EPCs and mEPCs before and after D-TC infusion. The bottom panel is a plot of the current in response
to intermittent application of carbachol. Despite the CCh induced currents being 200 times larger than the combined total EPC and mEPC currents in the same recording cycle, the D-TC-induced
increase in QC is robust. E, Desensitization of nAChRs does not trigger an increase in QC. Plots of average EPC, mEPC, and QC obtained using the protocol shown in Figure 1Bb. Despite a 40% reduction
in EPC and mEPC amplitudes (measured at the time indicated by the red symbols), there was no increase in QC. F, Averaged EPC and mEPC traces before (gray) and (Figure legend continues.)
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triggered the normal increase in QC (Fig. 2A). These data indicate
that muscarinic AChRs are not involved in D-TC-induced increase in QC at the NMJ.
Due to the rapidity of the upregulation of QC after D-TC, it
has been hypothesized that block of presynaptic nAChRs triggers
the upregulation (Bowman et al., 1990; MacDermott et al., 1999).
D-TC-sensitive ␣7-subunit-containing nAChRs are found on
many presynaptic terminals in the CNS (Albuquerque et al.,
2009) such that block of this type of nAChR could be involved in
the D-TC-induced increase in QC. ␣-CtxArIB is a rapid-acting
blocker of ␣7 containing nAChRs (Whiteaker et al., 2007; Innocent et al., 2008) and ␣-CtxArIB triggered no increase in QC (Fig.
2A). Furthermore, the increase in QC triggered by application of
D-TC was unaffected by prior block of ␣7 nAChRs with
␣-CtxArIB. We also applied D-TC to NMJs from mice lacking the
␣7 AChR subunit (␣7 KO mice) and found an increase in QC that
was similar to the increase present in wild-type siblings (Fig. 2A).
These data suggest block of presynaptic ␣7 containing nAChRs is
not the trigger for the increase in QC.
␣1-containing nAChRs are present in high concentration on
the postsynaptic muscle fiber at the NMJ and, to our knowledge,
have not been shown to be expressed by either motor neurons or
Schwann cells. ␣-CtxMI is a selective blocker of ␣1-containing
nAChRs (Johnson et al., 1995; Luo and McIntosh, 2004) and it
triggered an increase in QC similar to that seen with D-TC (Fig.
2B). These data strongly suggest that block of ␣1-containing
nAChRs on muscle is the trigger for upregulation of QC.
Upregulation of QC is independent of synaptic transmission
Synaptic current through nAChRs is primarily carried by Na ⫹
and K ⫹ ions, but there is significant Ca 2⫹ current as well (Bregestovski et al., 1979; Adams et al., 1980; Vernino et al., 1994). At
the mouse, frog, and Drosophila NMJ, it has been proposed that
Ca 2⫹ flow through postsynaptic receptors is sensed to trigger
homeostatic plasticity (Frank et al., 2006; Ouanounou et al.,
2016). Changes in Ca 2⫹ entry through nAChRs will be relatively
insensitive to changes in holding potential becauase the driving
force for Ca 2⫹ entry is large. Therefore, the lack of effect of
changing holding potential does not rule out a role for Ca 2⫹
current through nAChRs.
To examine the possibility that reduced Ca 2⫹ entry through
nAChRs is sensed, we increased synaptic current by directly applying agonist during infusion of D-TC. Carbachol (CCh) was
selected as the agonist as it causes less desensitization than ACh.
The duration and amplitude of the CCh-gated current in response to intermittent application of CCh was far greater than the
amplitude of currents carried by mEPCs and EPCs, yet pulsatile
application of CCh did not prevent the upregulation of QC triggered by D-TC (Fig. 3A–C, n ⫽ 11 NMJs from 6 mice). These data
demonstrate that D-TC can still trigger an increase in QC, even
when Ca 2⫹ entry is greatly increased relative to baseline by puffs
of CCh. A caveat is that the large increases in Ca 2⫹ entry through

4
(Figure legend continued.) in the presence of ACh (red) taken from times corresponding to
colored symbols on the plots shown in D. G, Mean data from 10 muscles treated with ACh: n ⫽
43 NMJs before and 102 NMJs during ACh infusion (Table 1). H, Mean data from 8 muscles before
(white, n ⫽ 38 NMJs) treated with ACh 0.1 mM and atropine 10 M (gray, n ⫽ 43 NMJs) and
with addition of 0.1 M D-TC (red, n ⫽ 56 NMJs). Nested analysis showed significant reductions
in EPC and mEPC amplitude after application of ACh and further significant reductions after
addition of D-TC. **p ⬍ .01. QC was statistically increased after D-TC infusion, whereas application of ACh and atropine alone had no effect (Table 1).
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nAChRs triggered by CCh do not mimic the small pulsatile Ca 2⫹
entry occurring during mEPCs.
We wished to determine whether we could reduce Ca 2⫹ entry
during mEPCs without triggering an increase in QC. We reduced
the amplitude of mEPCs by application of ACh to trigger desensitization. To further confirm that upregulation of QC is independent of the reduction in synaptic current/Ca 2⫹ entry, we
reduced the amplitudes of synaptic currents by application of
ACh to trigger desensitization. We applied ACh to the bath at a
dose (0.3– 0.5 mM) that reduced mEPC amplitude by ⬎30%. This
degree of reduction in mEPC amplitude normally reliably triggers an increase in QC after application of D-TC. However, when
mEPC amplitude was reduced by desensitization of nAChRs,
there was no increase in QC (Fig. 3D–F ). Similar results were
obtained with 10 to 30 M CCh (n ⫽ 10 NMJs, data not shown).
These results are consistent with the possibility that reduction in
Ca 2⫹ entry/current during mEPCs is not what is sensed to trigger
the upregulation of QC.
We next considered whether an aspect of synaptic function
that we did not measure might be involved in signaling the increase in QC. Several studies have suggested there is nonvesicular
release of ACh that is continuous (Katz and Miledi, 1977; Vyskocil et al., 2009). Such nonvesicular release is undetectable in our
recording conditions. The amount of continuous ACh release has
been hypothesized to be two orders of magnitude greater than
that released during mEPCs (Katz and Miledi, 1977; Vyskocil et
al., 2009). Perhaps block of this continuous neurotransmission
underlies the induction of the increase in QC. We tested whether
increasing continuous ACh signaling could prevent the D-TC
effect by adding ACh to the bath. We used 0.1 mM ACh, a dose
that triggers relatively mild desensitization of nAChRs and thus
would be expected to greatly increase continuous ACh-mediated
current. To avoid the possibility of activation of muscarinic
nAChRs by the addition of ACh, 10 M atropine was also added.
The increase in QC after application of D-TC was unaffected by
the addition of ACh to the bath (Fig. 3H ). These data suggest that
increasing continuous activation of nAChRs by application of
agonist has no effect on the signaling triggered by application of
D-TC.
Efficacy of different blocker of nAChRs
We wished to determine whether all blockers of nicotinic
nAChRs had the same efficacy in triggering the increase in QC. It
has been reported that vecuronium blocks nAChRs, but does not
trigger an increase in QC (Tian et al., 1994). However, when we
applied vecuronium, the QC increase was similar to other blockers of nAChRs (Fig. 4A). We measured the efficacy of both competitive and noncompetitive blockers of nAChRs. Both D-TC
and gallamine are reversible competitive antagonists (Rang et al.,
2003; Ostroumov et al., 2008). Mecamylamine is a noncompetitive antagonist that does not block binding of ACh to the nAChR
but instead is an open-channel blocker (Varanda et al., 1985). We
compared the efficacies of gallamine and mecamylamine with
those of D-TC, vecuronium, and BTX and found that all of these
blockers had similar efficacy in increasing QC (Fig. 4B). In contrast, succinylcholine blocked nAChRs, as indicated by the decrease of mEPC amplitude, but has partial agonist activity
(Marshall et al., 1990; Baraka, 2007) and did not trigger QC upregulation (Fig. 4C,D).
It is possible that because of the partial agonist activity, mEPC
amplitude was not reduced to the same extent as after application
of blockers with no agonist activity and this was why QC was not
increased after application of ACh and succinylcholine. To inves-
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Figure 4. Upregulation of QC occurs only in blockers with no agonist activity. A, Application of vecuronium triggers upregulation of QC. Left, Plot of average EPC and mEPC amplitude and QC before
and after infusion of vecuronium (0.25 M) at the time indicated. Right, Averaged EPC and mEPC traces before (gray) and in the presence of vecuronium (red) taken from times corresponding to
colored symbols on the plot on the left. Below are plots of mean EPC, mEPC, QC, and mEPC amplitude before (n ⫽ 10 muscle, 35 NMJs), during (n ⫽ 10 muscles, 99 NMJs) and after washout of
vecuronium (n ⫽ 10 muscles, 45 NMJs. For these experiments, muscle was held at ⫺70 mV and contraction was prevented by addition of 2 M (Figure legend continues.)
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tigate this, we compared the magnitude of reduction of mEPC
amplitude with the percentage increase in QC for all blockers
tested and found that the reduction in mEPC amplitude was
similar after drugs that did and did not trigger increased QC (Fig.
4 E, F ). Therefore, the lack of increase in QC could not be explained by a less severe block of synaptic transmission.
Increase in QC is associated with a speeding of mEPC decay
If block of nAChRs does not trigger increased QC by reducing
synaptic current, what possible explanations remain? We considered the possibility that nAChRs undergo a conformational
change after application of blocker. Evidence consistent with a
conformational change in nAChRs came from analysis of the rate
of decay of mEPCs. After partial block of nAChRs with blockers
with no agonist activity, there was a small, but statistically significant increase in the rate of decay of mEPCs (Fig. 5). At CNS
synapses, the presence of multiple receptor types made up of
different mixes of subunits means that changes in the kinetics of
currents could be due to preferential block of certain receptor
subtypes. This is not the case at the mouse NMJ, where there is
only one type of nAChR at the adult NMJ that is made up of an
identical mix of subunits (Unwin, 2013; Auerbach, 2015). Therefore, the more rapid mEPC decay could indicate a change in
behavior of the adult ␣1-containing muscle AChR.
It is known that the time constant of mEPC and EPC decay
and the mean open time of ACh-gated channels is voltage dependent (Magleby and Stevens, 1972); however, we voltage clamped
individual NMJs at the same potential before and after toxin
application and therefore voltage-dependent differences in
nAChRs open time does not explain the differences in mEPC
decay. Another possible explanation for the increase in rate of
mEPC decay is that blockers decrease the density of ACh-binding
sites and thereby accelerate the diffusion of ACh from the synaptic cleft, which is manifested by more rapid decay of the synaptic
current (Katz and Miledi, 1973).
If a conformational change in nAChRs is involved in signaling
the increase in QC, then blockers that trigger the increase in QC
should trigger an increase in rate of decay even if they have different mechanisms of action. Consistent with this possibility,
blockers that triggered increased QC had significant shortening
of mEPC decay time (Fig. 5B). In the case of mecamylamine,
single-channel recordings have shown that the increase rate of
decay is likely secondary to a shorter channel open time (Varanda
4
(Figure legend continued.) -Ctx (Table 1). B, Application of mecamylamine triggers upregulation of QC. The same experimental protocol was used as described in A for vecuronium. Mecamylamine (12 M) triggered similar changes in EPC and mEPC amplitude and a similar increase in
QC. Bottom summarizes data from 6 muscles before mecamylamine (n ⫽ 31 NMJs) and during
(n ⫽ 32 NMJs) and after washout (n ⫽ 43 NMJs) (Table 1). C, Application of succinylcholine fails
to trigger upregulation of QC. Left, Plot of average EPC and mEPC amplitude and QC before and
after infusion of succinylcholine (1 M) at the time indicated. D, Averaged EPC and mEPC traces
before (gray) and in the presence of succinylcholine (red), taken from times corresponding to
colored symbols on the plot shown in C. Bottom, mean data from 10 muscles treated with
succinylcholine (500 nM): n ⫽ 61 NMJs before, n ⫽ 87 NMJs during succinylcholine infusion,
and 76 NMJs after washout (Table 1). E, Comparison of changes in mEPC amplitude (gray
triangle) and QC (red circle) induced by infusion of ACh (left) or by infusion of mecamylamine
(right). All the values shown were normalized to the average value (as 100%) from the beginning of the plots, respectively. Although mEPC amplitude was reduced by a similar proportion,
QC increased during mecamylamine infusion, but not ACh infusion. F, Summary of changes in
mEPC amplitude and QC induced by BTX (control, 51 NMJs and BTX, 78 NMJs), D-TC (29 and 25),
gallamine (33 and 55), mecamylamine (Meca, 31 and 43), vecuronium (33 and 99), succinylcholine (suc, 61 and 87), and ACh (43 and 102). **p ⬍ .01. Averaged values were scaled to
controls, which were set at 100%.

et al., 1985). Succinylcholine, the only nAChR blocker that did
not trigger an increase in QC, triggered prolongation in mEPC
decay rather than a shortening. This increase in decay time has
been shown to be due to a longer open time of ACh-activated
currents (Nojima et al., 1992). Desensitization of nAChRs with
ACh or CCh triggered a slight, but statistically significant, speeding of mEPC decay. The increase in decay rate after desensitization was statistically significantly less than the increase in decay
rate induced by blockers that triggered the increase in QC (Fig. 5).
Because desensitization of nAChRs with ACh or CCh decreases
the number of unoccupied ACh-binding sites, there should have
been a similar increase in diffusion of ACh such that mEPC decay
should have been similarly shortened. The finding that mEPC
shortening was less after desensitization is consistent with the
possibility that part of the shortening is due to a conformational
change in unblocked nAChRs.

Discussion
It has been proposed that disruption of synaptic transmission is
sensed to trigger homeostatic upregulation of QC at the NMJ
(Rich and Wenner, 2007; Frank, 2014; Davis and Müller, 2015).
Studies performed to determine how disruption of synaptic
transmission is sensed led us to propose that interruption of synaptic transmission may not be what is sensed to trigger synaptic
plasticity at the mouse NMJ. We instead suggest that muscle ␣1containing nicotinic nAChRs may serve as signaling molecules
that trigger synaptic plasticity at the NMJ.
Technical considerations
Given the surprising nature of our hypothesis that block of postsynaptic AChRs triggers directly an increase in presynaptic release of ACh within seconds, it is worth considering the
possibility that our findings are due to an artifact of the way that
we performed the experiments. For example, the change in QC
could be due to different ACh concentrations during the EPC and
mEPC; because of the much higher concentration of ACh in the
synaptic cleft during the EPC than in mEPC, antagonist blockade
could more efficiently decrease the mEPC compared with the
EPC, thus altering the EPC/mEPC ratio. This issue would be
compounded if there was focal multivesicular release, as has been
demonstrated at CNS synapses (Wadiche and Jahr, 2001;
Taschenberger et al., 2002). Alternatively, there could be an issue
with voltage clamp of the larger EPC and better clamp is achieved
after partial block of nAChRs. Both of these possibilities would
lead to the incorrect conclusion that QC was increased after partial block of nAChRs. Supporting both of these possibilities is the
finding that, when QC is lowered by decreasing external Ca 2⫹,
the increase in QC is no longer seen (Tian et al., 1994; Wang et al.,
2016).
What then, is our evidence that the increase in QC is real? One
finding suggesting the increase is real is that block with BTX
triggers the same increase as D-TC. BTX binds nAChRs with high
affinity (Lukas et al., 1981) such that a higher concentration of
ACh in the cleft during evoked release will not overcome block.
Furthermore, the increase can be prevented by two manipulations that have minimal effect on EPC and mEPC amplitude. The
first manipulation is block of vesicle refilling with vesamicol. Although this eventually leads to reduction of EPC amplitude, before causing a significant reduction in EPC amplitude it
eliminates the increase in QC after infusion of D-TC (Wang et al.,
2016). Second, mice that have Ca 2⫹ indicator dye expressed presynaptically (perhaps buffering presynaptic Ca 2⫹) have normal
EPC amplitude, but a significantly blunted increase in QC after
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(synaptic scaling) (Turrigiano et al., 1998;
Burrone et al., 2002; Stellwagen and
Malenka, 2006). If this is the case, then it
would suggest that the way in which disruption of synaptic activity is sensed at
central synapses is fundamentally different
from the way that disruption is sensed at
the NMJ. However, it was recently demonstrated that restoring network activity
to baseline levels in the presence of ongoing block of neurotransmission had no effect on synaptic scaling (Fong et al., 2015;
Garcia-Bereguiain et al., 2016). These
findings strongly suggest blocking neurotransmitter receptors is sufficient to
trigger homeostatic plasticity independent of network activity in the CNS and
raise the possibility that the signals triggering homeostatic regulation are similar
at CNS synapses and the NMJ.
At CNS synapses, homeostatic synaptic plasticity can also be triggered by
blocking Na channels rather than neurotransmitter receptors (Turrigiano et al.,
1998; Burrone et al., 2002; Stellwagen and
Malenka, 2006). Do similar forms of homeostatic plasticity exist at the NMJ? At
the mouse NMJ, block of evoked activity
triggers an increase in probability of vesicle release and an increase in quantal amplitude that is independent of nAChR
block (Wang et al., 2004, 2005, 2010) and,
at the Drosophila NMJ, postsynaptic overexpression of K channels triggers an increase in QC despite normal activation of
glutamate receptors (Paradis et al., 2001).
These forms of synaptic plasticity appear
Figure 5. Upregulation of QC correlates with an increase in decay rate of mEPC. A, Plots of averaged mEPC amplitude (triangle), to be triggered by disruption of activation
decay tau* (circle), and QC (square) against time. Data were acquired using a protocol shown in Figure 1A. BTX (200 g/ml) was of the presynaptic nerve terminal or the
pressure puffed onto the endplate at the time indicated by the arrow. Left top, Superimposed mEPC traces (left) and peak postsynaptic muscle fiber rather than
normalized traces (right) shown were averaged from the time points indicated by the gray and red filled symbols on the mEPC plot block of neurotransmitter receptors and
(middle). For reference, same colorations apply to symbols in QC plot (bottom). B, Decay constant of mEPCs in the presence of drug thus represent homeostatic synaptic plasrelative to that of control. The same endplate was used to obtain mEPC values in the presence and absence of drug and the number
ticity that is triggered by disruption of
of endplates in each case is indicated in parentheses. Statistically significant decrease in normalized decay time constant was seen
synaptic transmission. This suggests that
in all pairs (except for an increase in succinylcholine) (Table 1). Comparison of mEPC decay time constant reduction between the
ACh/CCh group and the BTX group yielded significance (t(38) ⫽ 4.197, p ⫽ 1.57E-4, t test). GT, Gallamine. C, Scattered plots of at both the NMJ and central synapses
mEPC decay tau before and in the presence of nAChR antagonists. Two measurements of each endplate are connected by a colored there are at least two different sensors that
line. Data are from the same experiments shown in B (Table 1). *The rate of decay was measured as the time elapsed from the peak can independently trigger homeostatic
synaptic plasticity. Some sensors monitor
of the averaged mEPC to peak/e.
synaptic/network activity, whereas others
infusion of D-TC (Wang et al., 2016). Finally, mEPC and EPC
may sense factors that are independent of synaptic/network acamplitudes were reduced after application of ACh and succinyltivity. At the NMJ, each sensor engages different mechanisms to
choline without triggering an increase in QC. The finding that
homeostatically regulate synaptic strength (Wang et al., 2010).
synaptic current can be reduced without triggering an increase in
Differences between homeostatic regulation at the mouse and
QC rules out technical artifacts such as poor voltage clamp of
Drosophila NMJ
large currents. Our interpretation is that the increase in QC is real
The system in which the molecular mechanisms underlying hoand is due to mobilization of a unique pool of synaptic vesicles in
meostatic upregulation of QC has been studied in the greatest
a manner that is dependent on elevation of presynaptic Ca 2⫹
(Wang et al., 2016).
detail is the Drosophila NMJ. Most relevant to the current study,
two different retrograde signaling molecules have been identified
Triggers of homeostatic synaptic plasticity at
(Wang et al., 2014; Orr et al., 2017). The retrograde molecular
different synapses
signals act to modify presynaptic actin to potentiate the readily
It has been proposed that spiking activity is sensed by CNS neureleasable pool, increase insertion of DegENaC channels into the
rons to trigger homeostatic upregulation of quantal amplitude
presynaptic membrane, and increase Ca 2⫹ entry through presyn-
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aptic Cav2.1 channels (Müller and Davis, 2012; Younger et al.,
2013; Orr et al., 2017). All of these changes appear to contribute
to the increase in QC.
Could the same molecular signals underlie the retrograde homeostatic signaling occurring at the mouse NMJ? In both systems, block of postsynaptic neurotransmitter receptors triggers
an upregulation in presynaptic QC that occurs relatively rapidly.
Although the similarities suggest that the answer certainly could
be yes, there are two differences that suggest caution should be
used when extrapolating results from Drosophila to the mammalian NMJ. First, in the mouse, upregulation of QC occurs as rapidly as it can be measured (Wang et al., 2016). In Drosophila, there
is a several minute lag between block of receptors and upregulation of QC (Frank et al., 2006). Second, reduction of external
Ca 2⫹ concentration eliminates the upregulation of QC at the
mouse NMJ (Tian et al., 1994; Wilson et al., 1995; Wang et al.,
2016). In Drosophila, the increase in QC occurs at all levels of
extracellular Ca 2⫹ (Frank et al., 2006; Müller et al., 2015; Orr et
al., 2017). These dissimilarities suggest fundamental differences
in homeostatic mechanisms between the mouse and Drosophila
NMJ.
Type and location of nAChRs for which block triggers the
increase in QC
Two assumptions underlying our interpretation of the data are
that the nAChRs blocked are located on the postsynaptic muscle
fiber and that there is only a single type of nAChR present on the
muscle fiber. The data for and against our assumptions are considered below.
It has been hypothesized that block of ␣7-containing nicotinic
nAChRs present on the presynaptic nerve terminal at the NMJ is
responsible for the rapid upregulation of QC after block of
nAChRs (Bowman et al., 1990; MacDermott et al., 1999). We
ruled out involvement of presynaptic ␣7 nAChRs as the trigger
using ␣7 knock-out mice and toxins selective for the ␣1 versus ␣7
AChR subunits (Luo and McIntosh, 2004; Whiteaker et al.,
2007). Our data strongly suggest that block of ␣1-containing
nAChRs triggers the upregulation of QC. Because we are aware of
no evidence that either Schwann cells or the presynaptic motor
terminal express ␣-1-containing nAChRs, we favor the possibility that block of ␣-1-containing nAChRs on the postsynaptic
muscle fiber triggers the upregulation of QC.
A second possibility that would complicate interpretation is
that there might be two different types of nAChRs at the NMJ
with differential sensitivity to block. If spontaneous and evoked
release differentially activated the two nAChR subtypes, then this
could lead to erroneous conclusions about changes in QC after
block. For example, if the nAChRs preferentially activated by
spontaneous release were more sensitive to block, one could erroneously conclude that QC is increased after block. Support for
this possibility comes from studies at a number of different synapses, which suggest the vesicle pools responsible for evoked and
spontaneous release are distinct (for review, see Kavalali, 2015).
However, there is no evidence for multiple nAChR subtypes at
the adult, innervated NMJ (Unwin, 2013; Auerbach, 2015). Nevertheless, it remains possible that two populations exist and this
could account for our findings. The following data argue against
this possibility: when extracellular Ca 2⫹ is lowered, partial block
of nAChRs triggers no increase in QC (Tian et al., 1994; Wang et
al., 2016). Similarly, there is no nAChR block-induced upregulation of QC when vesamicol is added to prevent refilling of vesicles
(Wang et al., 2016). If there were two types of nAChRs differentially activated by spontaneous and evoked release and the

nAChR types had differential sensitivity to blockers, then one
would not expect there to be situations in which block of nAChRs
would not cause the apparent upregulation of QC.
How block of nAChRs is sensed
The nAChR-block-induced increase in QC did not require prior
evoked release and could be triggered in NMJs of fibers that were
voltage clamped. These data indicate that neither evoked release
nor membrane potential is sensed to trigger the increase in QC.
Another possibility is that Ca 2⫹/ion flow through nAChRs during spontaneous release of ACh is sensed (Bregestovski et al.,
1979; Vernino et al., 1994). Block of Ca 2⫹ flow through postsynaptic receptors has been proposed as the sensor for homeostatic
plasticity at the frog, mouse, and Drosophila NMJ (Frank et al.,
2006; Ouanounou et al., 2016). We addressed this possibility by
applying agonist and found no relationship between reduction of
current flow through nAChRs and upregulation of QC. These
data raise the possibility that reduction of neither Ca 2⫹ entry
nor synaptic current is the signal sensed. Further experiments
directly measuring Ca 2⫹ entry would be required to confirm
this conjecture.
One way that nAChRs could initiate signaling is by undergoing a conformational change. Evidence consistent with unblocked nAChRs undergoing a conformational change comes
from the finding that block of nAChRs triggers a small, but statistically significant increase in the rate of decay of mEPCs. The
increase in rate of decay cannot be explained by an effect of membrane potential on decay rate (Magleby and Stevens, 1972) or
competition between ligand and blocker (Wadiche and Jahr,
2001) because it occurs after block with an essentially irreversible
blocker (BTX). It is possible that the increase in decay rate is due
to occupation of ACh-binding sites, which leads to an increase in
the rate of diffusion of ACh out of the synaptic cleft (Katz and
Miledi, 1973). However, desensitization of nAChRs with ACh or
CCh also causes a decrease in ACh-binding sites available, but
does not trigger as big an increase in decay rate. Reduction of
mEPC amplitude by application of ACh and succinylcholine, two
treatments that did not trigger the same increase in decay rate, did
not trigger an increase in QC. These data raise the possibility that
there is a conformational change in unblocked nAChRs that may
be responsible for the increase in mEPC decay.
The signaling role that we are proposing for nAChRs at the
NMJ has been termed noncanonical signaling (Valbuena and
Lerma, 2016). In noncanonical signaling, ionotropic neurotransmitter receptors also serve as signaling molecules. Noncanoncial
signaling involving nAChRs has been shown previously in leukocytes (Razani-Boroujerdi et al., 2007; Hecker et al., 2015; Richter
et al., 2016). Ours is the first study to suggest that postsynaptic
nAChRs may be involved in noncanonical signaling that regulates
synaptic function and that noncanonical signaling may be involved
in triggering homeostatic synaptic plasticity. Because nAChRs have
been implicated in a number of disease states involving the nervous
system (Del Bufalo et al., 2014; Deutsch et al., 2015; Lombardo and
Maskos, 2015), the hypothesis that nAChRs may trigger synaptic
plasticity directly has wide-reaching implications.
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